Sources Attal N, Cruccu G, Haanpää M, et al; EFNS Task Force. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006;13(11):1153-69.
Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132(3):237-51.
Gilron I, Watson CPN, Cahill CM, et al. Neuropathic pain: a practical guide for the clinician. CMAJ. 2006;175(3):265-75. Oxman MN, Levin MJ, Johnson GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271-84.
Schmader K. Herpes zoster and postherpetic neuralgia in older adults. Clin Geriatr Med. 2007;23(3):615-32.
Wallace JM. Update on pharmacotherapy guidelines for treatment of neuropathic pain. Curr Pain Headache Rep. 2007;11(3):208-14.
Evans RW. Headaches in patients over the age of 50. In: Evans RW (Ed), Saunders Manual of Neurologic Practice. Philadelphia: Saunders;2003:461-3.
Hill;2005:631-59. edition. New York: McGraw-
Viral infections of the nervous system, chronic meningitis, and prion diseases. In: Ropper AH, Brown RH (Eds), Adams and Victor's Principles of Neurology, 8th
Abbreviations CBC, complete blood count; d, day; EIA, enzyme immunoassay; FDA, Food and Drug Adminis- tration; GBP, gabapentin; HSV, Herpes simplex virus; HZ, Herpes zoster; IFA, immunofluorescence antigen; MAOI, monoamine oxidase inhibitor; PCR, polymerase chain reaction; PHN, posther- petic neuralgia; PI, Prescribing Information; subcut, subcutaneous; SNRI, serotonin–norepineph- rine reuptake inhibitor; TCA, tricyclic antidepressant; tid, 3 times a day
Disclaimer
This Guideline attempts to define principles of practice that should produce high-quality patient care. It focuses on the needs of primary care practice, but also is applicable to providers at all levels. This Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aſter consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool.
PHN061119
5740 Executive Drive Suite 218 Baltimore, MD 21228 TEL: 410-869-3332 • FAX: 410-744-2150 For additional copies: orders@GuidelineCentral.com Copyright © 2012 All rights reserved
